全文获取类型
收费全文 | 1020篇 |
免费 | 65篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 48篇 |
妇产科学 | 9篇 |
基础医学 | 118篇 |
口腔科学 | 46篇 |
临床医学 | 100篇 |
内科学 | 224篇 |
皮肤病学 | 17篇 |
神经病学 | 38篇 |
特种医学 | 237篇 |
外科学 | 85篇 |
综合类 | 17篇 |
预防医学 | 39篇 |
眼科学 | 15篇 |
药学 | 41篇 |
肿瘤学 | 53篇 |
出版年
2023年 | 5篇 |
2022年 | 3篇 |
2021年 | 15篇 |
2020年 | 13篇 |
2019年 | 11篇 |
2018年 | 17篇 |
2017年 | 14篇 |
2016年 | 11篇 |
2015年 | 17篇 |
2014年 | 25篇 |
2013年 | 24篇 |
2012年 | 32篇 |
2011年 | 21篇 |
2010年 | 40篇 |
2009年 | 36篇 |
2008年 | 25篇 |
2007年 | 23篇 |
2006年 | 16篇 |
2005年 | 24篇 |
2004年 | 20篇 |
2003年 | 12篇 |
2002年 | 18篇 |
2001年 | 17篇 |
2000年 | 14篇 |
1999年 | 13篇 |
1998年 | 53篇 |
1997年 | 60篇 |
1996年 | 53篇 |
1995年 | 46篇 |
1994年 | 51篇 |
1993年 | 39篇 |
1992年 | 22篇 |
1991年 | 13篇 |
1990年 | 17篇 |
1989年 | 26篇 |
1988年 | 36篇 |
1987年 | 19篇 |
1986年 | 34篇 |
1985年 | 34篇 |
1984年 | 12篇 |
1983年 | 19篇 |
1982年 | 19篇 |
1981年 | 10篇 |
1980年 | 11篇 |
1979年 | 3篇 |
1978年 | 7篇 |
1977年 | 11篇 |
1976年 | 15篇 |
1975年 | 4篇 |
1940年 | 3篇 |
排序方式: 共有1091条查询结果,搜索用时 234 毫秒
61.
Macey L. Henderson Rebecca Hays Sarah E. Van Pilsum Rasmussen Didier A. Mandelbrot Krista L. Lentine Daniel G. Maluf Madeleine M. Waldram Matthew Cooper 《American journal of transplantation》2020,20(2):546-552
Although minimized by expert evaluation, operative technique, and postoperative care, the extremely low risk of perioperative mortality following living kidney or liver donation will never be eliminated. Furthermore, anticipation of poor donor outcome may simultaneously be a source of anxiety for physicians and programs and also be a circumstance for which they are unprepared. We conducted a national survey of US transplant surgeons to understand experiences with and systemic preparedness for the event of a living donor death. Respondents represented 87 unique transplant programs (71 kidney and 16 liver donor programs). Perioperative deaths were rare, as expected. Although most respondents (N = 57, 64% of total respondents; 88% of liver programs) reported being moderately to extremely concerned about a future living donor death at their institution, only 30 (33% of total program respondents) had a written plan available in the case of such an event; 63% of programs would find guidance and recommendations useful. To help address this gap, the American Society of Transplantation Live Donor Community of Practice (AST LDCOP) developed Living Donor Crisis Management Plan Talking Points suitable to guide crisis plan development at transplant programs. 相似文献
62.
Ellen Shukhman Julia Hunt Dianne LaPointe-Rudow Didier Mandelbrot Rebecca E. Hays Vineeta Kumar Heidi Schaefer Fawaz Al Ammary Macey L. Henderson Angie Nishio-Lucar Matthew Cooper Krista L. Lentine 《Clinical transplantation》2020,34(3):e13792
End-stage kidney disease patients in the United States may have family members or friends who are not US citizens or residents but are willing to serve as their living kidney donor in the United States (“international donors”). In July 2017, the American Society for Transplantation (AST) Live Donor Community of Practice (LDCOP) convened a multidisciplinary workgroup of experts in living donation care, including coordinators, social workers, donor advocates, administrators, and physicians, to evaluate educational gaps related to the evaluation and care of international donors. The evaluation of international living donor candidates is a resource-intensive process that raises key considerations for assessing risk of exploitation/inducement and addressing communication barriers, logistics barriers, and access to care in their home country. Through consensus-building discussions, we developed recommendations related to: (a) establishing program guidelines for international donor candidate evaluation and selection; (b) initial screening; (c) logistics planning; (d) comprehensive evaluation; and (e) postdonation care and follow-up. These recommendations are not intended to direct formal policy, but rather as guidance to help programs more efficiently and effectively structure and execute evaluations and care coordination. We also offer recommendations for research and advocacy to optimize the care of this unique group of living donors. 相似文献
63.
64.
Macey L. Murray Yingfen Hsia Karen Glaser Emily Simonoff Declan G. M. Murphy Philip J. Asherson Hanna Eklund Ian C. K. Wong 《Psychopharmacology》2014,231(6):1011-1021
Rationale
Autism spectrum disorders (ASDs) affect 1 % of children, having significant impact on health and social outcomes. Psychotropic medication use by individuals with ASD in the USA increased over time, and polypharmacy occurred in >50 % of those prescribed. In the UK, no psychotropic drugs are approved in ASDs, and little is known about patterns of pharmacological treatment in the ASD population and associated co-morbidities.Methods
We used The Health Improvement Network, a nationally representative primary care database, to assess the prevalence of ASD diagnoses, psychotropic drug prescribing and neuropsychiatric co-morbidities of 0–24 year olds between 1992 and 2008.Results
ASD prevalence increased 65-fold from 0.01 % (1992) to 0.50 % (2008). Psychotropic drugs were prescribed to 29 % (1,619/5,651) of the ASD cohort; the most prescribed drugs were sleep medication (9.7 % of prescribed patients), psychostimulants (7.9 %) and antipsychotics (7.3 %). More patients were given psychostimulants and sleep medications over time from 1.5–6.3 % and 2.2–5.9 % respectively. Thirty-seven per cent of the cohort had ≥1 record of a neuropsychiatric co-morbidity, the most common being developmental difficulties and learning disabilities (12.6 %), behavioural, conduct and personality disorders (11.1 %) and attention deficit hyperactivity disorder (7.5 %).Conclusions
British physicians are more conservative in prescribing practice than American colleagues. However, use of psychostimulants and antipsychotics is much higher in those with ASD than in the general population. Polypharmacy was seen in 34 % of prescribed patients in 2008. Additional studies examining use, efficacy, and long-term safety of antipsychotics and psychostimulants in autistic individuals are warranted. 相似文献65.
The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells 总被引:5,自引:0,他引:5
Interferons (IFNs) have been shown to have significant effects on hematopoietic cell growth. Previous studies defining these effects have utilized mouse and human alpha-, beta-, and gamma-IFN isolated from supernatants of stimulated cells. Despite purification, the possible presence of other lymphokines and soluble factors remains a concern. In this study, the effects of gene-cloned alpha- and gamma-IFN on colony- forming units of granulocyte/macrophage (CFU-GM) progenitors cultured from the peripheral blood of normal volunteers were examined. In addition, blast cell colonies from one patient with acute myelogenous leukemia (AML) were studied. The growth of normal CFU-GM and AML blast cell colonies was inhibited in a dose-dependent manner by gamma- and alpha-IFN. gamma-IFN was ten to 100 times more potent than alpha-IFN in that this species of IFN reduced colony formation by greater than 50% at concentrations of less than 15 antiviral U/mL. The effects of gamma- IFN were neutralized by a monoclonal antibody specific for gamma-IFN. These in vitro studies indicate that human gamma-IFN may be an important modulator of myelopoiesis. Although these data indicate a possible efficacy of gamma-IFN in the treatment of AML, the in vitro results should be considered for their in vivo significance. 相似文献
66.
67.
68.
69.
Tiffani J. Mungoven Kasia K. Marciszewski Vaughan G. Macefield Paul M. Macey Luke A. Henderson Noemi Meylakh 《The journal of headache and pain》2022,23(1)
BackgroundThe precise underlying mechanisms of migraine remain unknown. Although we have previously shown acute orofacial pain evoked changes within the brainstem of individuals with migraine, we do not know if these brainstem alterations are driven by changes in higher cortical regions. The aim of this investigation is to extend our previous investigation to determine if higher brain centers display altered activation patterns and connectivity in migraineurs during acute orofacial noxious stimuli.MethodsFunctional magnetic resonance imaging was performed in 29 healthy controls and 25 migraineurs during the interictal and immediately (within 24-h) prior to migraine phases. We assessed activation of higher cortical areas during noxious orofacial heat stimulation using a thermode device and assessed whole scan and pain-related changes in connectivity.ResultsDespite similar overall pain intensity ratings between all three groups, migraineurs in the group immediately prior to migraine displayed greater activation of the ipsilateral nucleus accumbens, the contralateral ventrolateral prefrontal cortex and two clusters in the dorsolateral prefrontal cortex (dlPFC). Reduced whole scan dlPFC [Z + 44] connectivity with cortical/subcortical and brainstem regions involved in pain modulation such as the putamen and primary motor cortex was demonstrated in migraineurs. Pain-related changes in connectivity of the dlPFC and the hypothalamus immediately prior to migraine was also found to be reduced with brainstem pain modulatory areas such as the rostral ventromedial medulla and dorsolateral pons.ConclusionsThese data reveal that the modulation of brainstem pain modulatory areas by higher cortical regions may be aberrant during pain and these alterations in this descending pain modulatory pathway manifests exclusively prior to the development of a migraine attack. 相似文献
70.